Skip to content

Clinical trials

Phase 1 Colorectal Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1 Country / region: Belgium Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20121
20133
20141
20152
20162
20172
20182
20195
20202
20214
20222
20232
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting10
Terminated8
Recruiting6
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Amgen3
Exelixis3
Genentech, Inc.3
Incyte Corporation3
Ipsen2
AbbVie1
Amal Therapeutics1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms36
Carcinoma, Non-Small-Cell Lung15
Neoplasms10
Squamous Cell Carcinoma of Head and Neck10
Neoplasm Metastasis8
Carcinoma, Renal Cell7
Triple Negative Breast Neoplasms7
Breast Neoplasms6
Stomach Neoplasms6
Carcinoma, Hepatocellular5

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.